Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
European Journal of Pharmacology|August 9, 2002
Biochemical characterization of desloratadine, a potent antagonist of the human histamine H(1) receptorJohn C Anthes, Helen Gilchrest, Christian Richard, et al.
Journal of Hazardous Materials|January 10, 2021
AC/DC magnetic device for safe medical use of potentially harmful magnetic nanocarriersMislav Mustapić, Zvonko Glumac, Marija Heffer, et al.
European Journal of Pharmacology|November 27, 2002
Identification of full, partial and inverse CC chemokine receptor 3 agonists using [35S]GTPgammaS bindingYuntao Wan, James P Jakway, Hongchen Qiu, et al.
American Journal of Respiratory Cell and Molecular Biology|January 12, 2001
A unique mRNA initiated within a middle intron of WHSC1/MMSET encodes a DNA binding protein that suppresses human IL-5 transcriptionC G Garlisi, A S Uss, H Xiao, et al.
Genome Biology|June 7, 2002
Microarray profile of differentially expressed genes in a monkey model of allergic asthmaJun Zou, Simon Young, Feng Zhu, et al.
Biochemical and Biophysical Research Communications|January 22, 2003
Human ADAM33: protein maturation and localizationCharles G Garlisi, Jun Zou, Kristine E Devito, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 15, 2007
Pharmacological characterization of Sch527123, a potent allosteric CXCR1/CXCR2 antagonistWaldemar Gonsiorek, Xuedong Fan, David Hesk, et al.
American Journal of Respiratory Cell and Molecular Biology|February 25, 1999
Effects of cyclosporin A and dinactin on T-cell proliferation, interleukin-5 production, and murine pulmonary inflammationS P Umland, H Shah, J P Jakway, et al.
Journal of Materials Chemistry. B|August 16, 2019
Nanoarchitectured peroxidase-mimetic nanozymes: mesoporous nanocrystalline α- or γ-iron oxide?Mostafa Kamal Masud, Jeonghun Kim, Md Motasim Billah, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 18, 2002
Pharmacology of N-(3,5-dichloro-1-oxido-4-pyridinyl)-8-methoxy-2-(trifluoromethyl)-5-quinoline carboxamide (SCH 351591), a novel, orally active phosphodiesterase 4 inhibitorM Motasim Billah, Nicola Cooper, Michael Minnicozzi, et al.
Pageof 3